Evidence map›Paper›PMID 30899540›Full record

ArticleJournal of clinical movement disorders2019

Transcranial magnetic stimulation therapy for focal leg dystonia: a case report.

Kush Sharma, Alberto Cucca, Andrea Lee, Shashank Agarwal, Steven Joel Frucht, Milton Cesar Biagioni

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Journal of clinical movement disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Beyond Pallidal or Subthalamic Deep Brain Stimulation to Treat Dystonia.Tremor and other hyperkinetic movements (New York, N.Y.) · 2024
    Review
  2. Review
  3. Review
  4. Article
  5. Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kush Sharma1The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU School of Medicine, 222 E 41st Street, 13th Floor, New York, NY 10017 USA.ORCID 0000-0002-2909-5707
Alberto Cucca1The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU School of Medicine, 222 E 41st Street, 13th Floor, New York, NY 10017 USA.
Andrea Lee1The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU School of Medicine, 222 E 41st Street, 13th Floor, New York, NY 10017 USA.
Shashank Agarwal1The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU School of Medicine, 222 E 41st Street, 13th Floor, New York, NY 10017 USA.
Steven Joel Frucht1The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU School of Medicine, 222 E 41st Street, 13th Floor, New York, NY 10017 USA.
Milton Cesar Biagioni1The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU School of Medicine, 222 E 41st Street, 13th Floor, New York, NY 10017 USA.
AOL (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDystonia is a debilitating disease that causes abnormal, often repetitive, movements, postures or both. The pathophysiology is unknown but related to loss of neuronal inhibition, aberrant sensorimotor integration, and/or derangements of synaptic plasticity. Current treatments include pharmacotherapy, botulinum toxin injections and deep brain stimulation (DBS). The response to these treatments are often limited and carry the risk of side effects requiring alternative therapies such as non-invasive brain stimulation. CASE PRESENTATION: We present a case report of a 65-year -old man with refractory focal 'task-specific' dystonia. The treatment plan included 10-daily sessions of 1 Hz, 2600 pulses of repetitive transcranial magnetic stimulation (rTMS) targeting the primary motor cortex.

conclusionThere were no clinical benefits noticed. Currently, there are no rTMS protocol treatments for dystonia. Publication of negative results will help in refining the optimal stimulation parameters, thus maximizing the effectiveness and reproducibility of future therapeutic protocols.

Indexed as

Dystonia therapyFocal dystoniaRepetitive transcranial magnetic stimulationTask-specific dystonia

Identifiers

PMID30899540
PMCPMC6408853
OpenAlexW2939281759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.